The Cannigma

DECEMBER 20, 2021

Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

The Cannigma

OCTOBER 6, 2022

But it likely doesn’t cause cancer like cigarettes do, as nicotine and cannabinoids tend to have different effects on our cells. There is also an association with an increase in phlegm production, and a potential increase in certain respiratory conditions. Related Stories. Can CBD help you quit smoking?

Vaping 90

Vaping Topical Data Safety 90

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

AUGUST 16, 2022

The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Cannabis Law Report

AUGUST 10, 2021

The approval, made through the European Commission Decision Reliance Procedure (ECDRP), is based on data from a positive Phase 3 safety and efficacy study evaluating 25 mg/kg/day of GW’s cannabidiol. The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety. www.igcinc.us www.igcpharma.com.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

APRIL 1, 2022

The General Council of Pharmacists has proposed this Monday to carry out a pilot test in pharmacies to assess the use of cannabis for therapeutic purposes, a product that, in the opinion of the president of pharmacists, could have a similar use and conditions of use to those that have other compounds such as morphine.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Use of Non-controlled Cannabinoids in Food.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

SpeedWeed

FEBRUARY 21, 2021

The human primary blood cell screens performed at MSU are state-of-the-science models for evaluating the effects of compounds on the human immune system,” said Kaminski, director of the Institute for Integrative Toxicology, Professor of Pharmacology & Toxicology, and director of MSU’s Center for Research on Ingredient Safety.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Cannigma

FEBRUARY 25, 2021

Importantly, unlike most other terpenes, beta-caryophyllene can interact directly with the endocannabinoid system and has even been described as a dietary cannabinoid. The ECS is best known for interacting with cannabinoids from the cannabis plant, like THC and CBD, and is responsible for much of the plant’s therapeutic effects.

Terpenes 107

Terpenes Oil Cannabinoids Conditions 107

Veriheal

JULY 7, 2022

Cannabis can help with a whole host of conditions, but some research has raised concerns about its potentially negative impact on the heart. The study analyzed data from around 500,000 people in order to investigate the relationship between cannabis and heart attacks.

THC 95

THC Medicine Cannabinoids Conditions 95

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

OCTOBER 29, 2020

Science Magazine explains that the ‘harms’ refer to the adverse effects and negative impacts of cannabis consumption while the ‘endocannabinoid system’ refers to the body’s cannabinoid receptors and naturally produced endocannabinoids which the cannabis cannabinoids bind to. It also shows that three countries (the U.S,

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

TheAnswerPage

FEBRUARY 25, 2022

Cannabis plants that contain higher amounts of the intoxicating psychoactive cannabinoid THC are used for medical purposes and as a recreational drug. 9 Tetrahydrocannabinol (THC), and industrial hemp for Cannabidiol (CBD), though both cannabinoids can be present in traditional marijuana and hemp. Chemical Classifications.

Sativa 40

Sativa Hybrid Terpenes Indica 40

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. Cannabinoids are chemical compounds found in the cannabis plant. The Straits Times Reports.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). For example, rather than having researchers carry out a controlled investigation, each study subject provided self-reported data.

Epilepsy 58

Epilepsy Pharmaceutical Patients Sleep 58

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. We could potentially develop north of 11,000 drugs that are cannabinoid-based. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

FEBRUARY 28, 2022

Scientists have discovered that CBD interacts with the receptors of the endo cannabinoid system in the central, peripheral, and central nervous systems. The CHF hopes that this study will provide the first scientific data on CBD usage in dogs with this condition. The majority of CBD products are derived from hemp and cannabis.

Oil 52

Oil Blood Pressure CBD Tincture 52

Cannabis Law Report

AUGUST 23, 2021

FDA has not reviewed the manufacturing process of these unapproved CBD-containing drug products, so the manufacturing conditions of, or contaminant levels in, these products is unknown. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

The Joint Blog

JANUARY 23, 2020

” The systematic review of the literature “was conducted during 2019, assessing the data from all case studies and clinical trials involving medicinal cannabis or plant-derived isolates for all major psychiatric disorders (neurological conditions and pain were omitted).”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. CB4 products are formulated based on the latest medical evidence and come in convenient dosage forms that deliver effective levels of cannabinoids. Opticann medical cannabis products merge cannabis medicine with modern medicine.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns.

THC 52

THC CBD Media Food 52

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

NOVEMBER 22, 2019

. “MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking.” For more information visit: [link]. For media inquiries please contact: Michael Sharp. 561-627-9455.

DEA 66

DEA Clinical Trials THC Research and Development 66

Ezra Parzybok

FEBRUARY 12, 2020

Up until a few years ago, the lack of knowledge about the condition most women embraced motherhood with complete ease naturally with no resistance at all. But today, more women are willing to seek a full range of options to help to cope with the conditions and to cherish a new beginning with their child. Postpartum Depression Care.

Research and Development 52

Research and Development Sleep Treatment CBD 52

Cannabis Law Report

MAY 19, 2022

In the Warning Letters, FDA expresses concern with the use of chemicals to convert other cannabinoids in the plant into delta-8 THC. FDA states it has serious safety concerns with delta-8 THC. FDA considers delta-8 THC to pose serious health and safety risks. and reduce anxiety and nervousness.”. meat, milk, and eggs).

THC 52

THC CBD Food Pets 52

Cannabis Law Report

FEBRUARY 15, 2019

Mr Shanmugam said this just before a joint statement by the Home Affairs and Health ministries which set out the government’s position the use of pharmaceutical products containing cannabinoids. They said, “To date, there are no studies which have validated the claims of unprocessed or raw cannabis being able to treat medical conditions,”.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

The Joint Blog

MARCH 16, 2020

According to a new study published in the journal Phytotherapy Research, the sustained use of marijuana in patients with chronic conditions is associated with quality of life maintenance and a lack of cognitive decline. Hair analysis was conducted to confirm the presence of cannabinoids.

Patients 49

Patients Marijuana Epilepsy Treatment 49

Otherside Farms

JANUARY 22, 2019

Despite the fact that marijuana is now legal in some form in 23 states (and in our nation’s capitol, the District of Columbia) and is often obtained through a doctor’s prescription, there is little the average person can do to ensure their cannabis is healthy and limited data available about the profile of a given cannabis strain.

Terpenes 40

Terpenes Strains Data Cannabinoids 40

The Joint Blog

APRIL 17, 2020

Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications.

Events 48

Events THC Chronic Pain Sleep 48